Eric Bjerkholt, CHIEF FINANCIAL OFFICER at Mirum Pharmaceuticals, Inc. (MIRM), sold 5,000 shares at $92.84 ($469K) on 2026-06-08, disclosed to the SEC on 2026-06-09.
Scheduled sale ($469k) by CHIEF FINANCIAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $92.84 | 2,258 | $210K | 44.7% |
| 2 | $93.95 | 1,175 | $110K | 23.5% |
| 3 | $95.12 | 1,567 | $149K | 31.8% |
| Total | $93.82 avg | 5,000 | $469K | 100% |
| Filing → |
| MIRM | SELL | 2026-07-08 | $611K | — | Filing → |
| CERS | SELL | 2026-06-11 | $53K | — | Filing → |
| MIRM | SELL | 2026-03-17 | $1.3M | — | Filing → |